Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review

被引：0
作者：
Francesca Conte
Lauren Banting
Helena J. Teede
Nigel K. Stepto
机构：
[1] Victoria University,Institute of Sport, Exercise and Active Living
[2] University of Padova,U.O.C. Sports Medicine, Department of Medicine
[3] Monash University,Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine
[4] Diabetes and Vascular Medicine Unit,undefined
[5] Monash Health,undefined
来源：
Sports Medicine | 2015年 / 45卷
关键词：
Mental Health; Physical Activity; Lifestyle Modification; Polycystic Ovary Syndrome; Mental Health Outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This review was designed to consider the available literature concerning mental health and physical activity in women with polycystic ovary syndrome (PCOS). A systematic approach was taken and two electronic databases (PubMed and EBSCO Research articles published between 1970 and 2013) were searched in 2013 to inform a narrative review. Inclusion criteria encompassed requirements for the research to involve a physical activity intervention and assessment of mental health outcomes in women with PCOS. Seven articles considered mental health outcomes and physical activity interventions for women with PCOS. The results demonstrated positive outcomes following physical activity intervention for health-related quality of life, depression, and anxiety. Only one paper reported the independent effects of physical activity on mental health. All other interventions included multi-factor lifestyle interventions or did not establish a control group. Physical activity is likely to be beneficial to the mental health of women with PCOS; however, more research is required to establish the nature of the relationship between physical activity and mental health outcomes.
引用
收藏
页码：497 / 504
页数：7
相关论文
共 166 条
[1]  
Asuncion M(2000)A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab. 85 2434-2438
[2]  
Calvo R(2006)Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab. 91 4237-4245
[3]  
SanMillan J(2012)Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare Reprod Biol Endocrinol. 10 96-2569
[4]  
Azziz R(2013)Prevalence of polycystic ovary syndrome in women in China: a large community-based study Hum Reprod. 28 2562-551
[5]  
Carmina E(2010)The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod. 25 544-3073
[6]  
Dewailly D(2012)Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria Hum Reprod. 27 3067-66
[7]  
Gabrielli L(2012)Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin Australia Med J Aust. 196 62-769
[8]  
Aquino EM(2005)Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance Fertil Steril. 84 766-1532
[9]  
Li R(2013)Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women Obesity. 21 1526-25
[10]  
Zhang Q(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-44
12345678910